RHON-KLINIKUM AG has reported a stable business performance for the first half of 2026, with consolidated revenue reaching EUR 863.6 million, slightly above the previous year's EUR 833.5 million. EBITDA improved to EUR 57.0 million from EUR 46.7 million, and consolidated profit rose to EUR 22.5 million from EUR 14.7 million. The results were significantly impacted by immediate transformation costs established until November 2026 to offset higher personnel and material costs from previous years.
From January to June, the Group treated a total of 513,700 patients on an outpatient and inpatient basis, marking a 9% increase compared to 471,295 in the same period of 2025. The company continues to invest in expanding regional health networks and modernizing medical technology across its sites.
In Hesse, Universitatsklinikum Marburg and the pulmonary clinic Lungenfachklinik Immenhausen have formed a strategic partnership to improve lung patient care. In Brandenburg, the newly opened child protection emergency service at the RHON-KLINIKUM Frankfurt (Oder) site is part of a strong regional network, with cooperation agreements between the hospital, the City of Frankfurt (Oder), and the District of Oder-Spree ensuring coordinated help for children and adolescents.
Dr. Gunther K. WeiB, member of the Board of Management, emphasized the importance of regional networks: “Regional networks form a vital and essential part of any future healthcare system. Rigid sectoral boundaries make it more difficult to provide patients with the care they need and saddle our healthcare system with unnecessary costs. It is only when general practitioners, specialists, medical facilities, nurses and therapists work together as a team that we can pool our resources efficiently.”
Dr. Stefan Stranz, also on the Board of Management, criticized recent legislative changes: “The Statutory Health Insurance Contribution Rate Stabilization Act imposes further burdens on hospitals. Instead of reducing bureaucracy and refocusing on patient care, the reform saddles already overburdened hospitals with even more documentation requirements, excessive budget cuts, and financial risks.”
For the full year 2026, the company expects revenues of EUR 1.7 billion (±5%) and EBITDA between EUR 110 million and EUR 125 million. The forecast is subject to significant uncertainties due to ongoing regulatory changes, including the Hospital Reform Adjustment Act (KHAG) and the SHI Contribution Rate Stabilisation Act (GKV-BStabG), which are likely to increase financial pressure on hospitals in the short term. Global crises and economic impacts, such as higher prices and supply bottlenecks, also contribute to market volatility.
The company's interim report for the first half of 2026 is available on its website: RHON-KLINIKUM AG.
